Today, the Center for Excellence in Brain Science and Intelligence Technology at the Chinese Academy of Sciences revealed a major milestone in the second clinical trial of an invasive brain-computer interface (BCI). This trial was carried out in partnership with domestic research institutions and medical organizations.

It successfully marked a technological leap, transitioning from two-dimensional screen cursor control to three-dimensional interaction in the physical world. Equipped with an implanted BCI device, the subject accurately controlled a robotic arm in three-dimensional space to perform grasping tasks. This achievement represents a significant technological advancement in China's field of invasive BCIs.

The trial utilized the world's smallest and most flexible neural electrodes, paired with independently developed real-time online decoding technology. This combination allowed for millisecond-level analysis of neural signals and ensured stable control across multiple days. The results pave the way for a novel approach to restoring motor function in patients suffering from spinal cord injuries, amputations, and other similar conditions through BCI technology.